|Number of samples:||7|
|Release date:||Jul 18 2016|
|Last update date:||Jan 23 2018|
|Diseases:||Breast Neoplasms, Neoplasms, Prostatic Neoplasms|
|Dataset link||Chromatin targets of androgen receptor and PIAS1 in molecular apocrine breast cancer cells [ChIP-seq]|
All ChIP-seq samples were collected from cells treated with 10 nM R1881 (synthetic androgen methyltrienolone) for 2 h. In addition, AR ChIP-seq samples were collected from cells exposed to control siRNA (siNON, Dharmacon Non-targeting pool) or PIAS1 siRNA (siPIAS1, Dharmacon ON-TARGETplus SMARTpool for human PIAS1). IgG sample was collected from siNON and siPIAS1 cells and used as background control. Biological duplicate samples of the AR, PIAS1 and single IgG ChIP-seq samples were analyzed by using Solexa/Illumina 1.5.